Utilisation of Serum Neurofilament Light in a Tertiary MS Clinic in Australia

被引：0
|
作者：
Fontes-Villalba, Ariadna [1 ,2 ]
Montague, Thomas [1 ]
Cheung, Emily [1 ]
Chatterton, Sophie [1 ]
Parratt, John [1 ,2 ]
机构：
[1] Royal North Shore Hosp, St Leonards, NSW, Australia
[2] Univ Sydney, Camperdown, NSW, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P612/1917
引用
收藏
页码：476 / 476
页数：1
相关论文
共 50 条
  • [1] Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
    van Lierop, Zoe Y. G. J.
    Wessels, Mark H. J.
    Lekranty, Womei M. L.
    Moraal, Bastiaan
    Hof, Sam N.
    Hogenboom, Laura
    de Jong, Brigit A.
    Meijs, Nandi
    Mensing, Liselore A.
    van Oosten, Bob W.
    Sol, Nik
    Kempen, Zoe L. E. van
    Vermunt, Lisa
    Willems, Myrthe J.
    Strijbis, Eva M. M.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Teunissen, Charlotte E.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (13) : 1620 - 1629
  • [2] Impact of serum neurofilament-light on clinical decision making in a tertiary multiple sclerosis clinic
    Wessels, Mark
    van Lierop, Zoe
    Lekranty, Womei
    Moraal, Bastiaan
    Hof, Sam
    Hogenboom, Laura
    Brigit, de Jong
    Meijs, Nandi
    Mensing, Liselore
    van Oosten, Bob
    Sol, Nik
    van Kempen, Zoe
    Vermunt, Lisa
    Willems, Myrthe
    Strijbis, Eva
    Uitdehaag, Bernard
    Killestein, Joep
    Teunissen, Charlotte
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 585 - 586
  • [3] Towards optimized monitoring of serum neurofilament light chain in ms
    Uher, T.
    Kuhle, J.
    Bergsland, N.
    Krasensky, J.
    Javor, A.
    Srpova, B.
    Barro, C.
    Dwyer, M.
    Tyblova, M.
    Benkert, P.
    Leppert, D.
    Havrdova, E.
    Vaneckova, M.
    Zivadinov, R.
    Kalincik, T.
    Horakova, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 202 - 202
  • [4] Serum neurofilament light in the clinic: comparing stabilization under natalizumab with ocrelizumab
    Wessels, Mark
    Hogenboom, Laura
    van Lierop, Zoe
    Coerver, Eline
    Moraal, Bastiaan
    Barkhof, Frederik
    van Kempen, Zoe
    Teunissen, Charlotte
    Killestein, Joep
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 893 - 894
  • [5] Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
    Thebault, Simon
    Booth, Ronald A.
    Rush, Carolina A.
    MacLean, Heather
    Freedman, Mark S.
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [6] Serum neurofilament light chain in MS: association with clinical and MRI measures
    Oldoni, E.
    Smets, I.
    Gille, B.
    Mallants, K.
    Poesen, K.
    Dubois, B.
    Goris, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 885 - 885
  • [7] Serum neurofilament light chains in MS Association with the Timed Up and Go
    Allali, Gilles
    Kuhle, Jens
    Breville, Gautier
    Leppert, David
    Armand, Stephane
    Lalive, Patrice H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (06):
  • [8] Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes
    Wong, Yu Yi M.
    Bruijstens, Arlette L.
    Barro, Christian
    Michalak, Zuzanna
    Melief, Marie-Jose
    Wierenga, Annet F.
    van Pelt, E. Danielle
    Neuteboom, Rinze F.
    Kuhle, Jens
    Hintzen, Rogier Q.
    NEUROLOGY, 2019, 93 (10) : E968 - E974
  • [9] Serum neurofilament-light concentration and real-world outcome in MS
    Anderson, Valerie
    Bentley, Emily
    Loveless, Sam
    Bianchi, Lucia
    Harding, Katharine E.
    Wynford-Thomas, Ray A.
    Joseph, Fady
    Giovannoni, Gavin
    Gnanapavan, Sharmilee
    Robertson, Neil P.
    Marta, Monica
    Tallantyre, Emma C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 417
  • [10] Serum neurofilament light as a biomarker of disability and neurodegeneration in MS patients of the same age
    Loonstra, F. C.
    De Ruijter, L. R. J.
    Schoonheim, M. M.
    Strijbis, E. M.
    Moraal, B.
    Bijvank, J. A. Nij
    Petzold, A.
    Uitdehaag, B. M. J.
    Teunissen, C. E.
    Killestein, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 509 - 510
12345